婴儿中耳胚胎型横纹肌肉瘤1例并文献复习

doi:10.6040/j.issn.1673-3770.0.2021.409

摘要/Abstract

摘要： 目的提高耳鼻喉科临床医师对婴儿中耳横纹肌肉瘤的认识。方法对1例婴儿中耳胚胎型横纹肌肉瘤进行临床资料分析并复习相关文献。结果患儿女,10月龄,患儿家长发现患儿左侧耳道肿物,伴耳道少量出血。CT及MRI提示左侧外耳道、鼓室及乳突内占位性病变,咽旁间隙、颈部、双侧腋窝淋巴结转移。通过活检手术后病理及免疫组化检查确诊为横纹肌肉瘤。患儿放化疗结束4个月后,因颅脑转移死亡。结论发生在婴儿中耳的横纹肌肉瘤少见,且位置隐匿,早期无典型临床表现,容易造成误诊及漏诊;该病恶性程度高,临床上应争取早发现、早诊断及早治疗,提高患者生存率。

关键词: 中耳, 胚胎型, 横纹肌肉瘤, 婴儿, 恶性肿瘤

Abstract: Objective Raising awareness of otolaryngologists on embryonal rhabdomyosarcoma disease. Methods The clinical data of an infant with embryonal rhabdomyosarcoma in the middle ear were analyzed, and related literatures were reviewed. Results The patient was a 10-month-old female with a bleeding mass in the left external auditory canal. Computed tomography and magnetic resonance imaging revealed soft tissue density shadows in the left external auditory meatus, tympanum, and mastoid sinus that were accompanied with an enlarged lymph node in the parapharyngeal, neck and bilateral axilla. Moreover, the diagnosis of RMS was confirmed by postoperative pathological and immunohistochemical examination after biopsy. The patient died of brain metastasis four months after the end of radiation and chemotherapy. Conclusion RMS in the middle ear is rare. Due to its obscure location and lack of typical clinical manifestations in the early stage, RMS is difficult to detect and prone to misdiagnosis. The malignant degree of this disease is high. Thus, the early detection, diagnosis, and treatment of this disease should be further studied to improve the survival rate of patients.

Key words: Middle ear, Embryonic, Rhabdomyosarcoma, Infant, Malignancy

中图分类号:

R764.2

李玲,李聪,孙岩,陈良. 婴儿中耳胚胎型横纹肌肉瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 55-59.

LI Ling, LI Cong, SUN Yan, CHEN Liang. A case of an infant with embryonal rhabdomyosarcoma in the middle ear and literature review[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(1): 55-59.

参考文献

[1] 中国抗癌协会小儿肿瘤专业委员会, 中华医学会儿科学分会血液学组, 中华医学会小儿外科学分会肿瘤组. 中国儿童及青少年横纹肌肉瘤诊疗建议(CCCG-RMS-2016)[J]. 中华儿科杂志, 2017, 55(10): 724-728. doi:10.3760/cma.j.issn.0578-1310.2017.10.002.
[2] Hayes SM, Biggs TC, Bird JH, et al. Rhabdomyosarcoma of the middle ear cavity presenting with Horner's syndrome[J]. Annals, 2019, 101(1): e8-e10. doi:10.1308/rcsann.2018.0157.
[3] 何健, 钱立庭, 高劲. 外耳道腺样囊性癌侵犯中耳、颞叶且伴颈部淋巴结转移一例报告[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 109-111,118. doi: 10.6040/j.issn.1673-3770.0.2017.424. HE Jian, QIAN Liting, GAO Jin. A case of external auditory canal adenoid cystic carcinoma invading the middle ear and temporal lobe, with cervical lymph node metastasis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2018,32(6): 109-111,118. doi: 10.6040/j.issn.1673-3770.0.2017.424.
[4] 赵笑冰, 张大为, 陈仁杰. 中耳间变性大 T 细胞淋巴瘤一例并文献复习[J/OL].山东大学耳鼻喉眼学报,2022[2022-02-18]. doi:10.6040/j.issn.1673-3770.0.2021.318. ZHAO Xiaobing, ZHANG Dawei, CHEN Renjie. A case of middle-ear anaplastic large T- cell lymphoma and literature review[J]. J Otolaryngol Ophthalmol Shandong Univ, 2022[2022-02-18]. doi:10.6040/j.issn.1673-3770.0.2021.318.
[5] Jo VY, Fletcher CDM. WHO classification of soft tissue tumours: an update based on the 2013(4th)edition[J]. Pathology, 2014, 46(2): 95-104. doi:10.1097/PAT.0000000000000050.
[6] Leiner J, Le Loarer F. The current landscape of rhabdomyosarcomas: an update[J]. Virchows Arch, 2020, 476(1): 97-108. doi:10.1007/s00428-019-02676-9.
[7] Fischer TD, Gaitonde SG, Bandera BC, et al. Pediatric-protocol of multimodal therapy is associated with improved survival in AYAs and adults with rhabdomyosarcoma[J]. Surgery, 2018, 163(2): 324-329. doi:10.1016/j.surg.2017.10.027.
[8] Janz TA, Camilon PR, Cheung AY, et al. A review of pediatric middle ear tumors and analysis of the demographics, management, and survival of pediatric rhabdomyosarcomas of the middle ear[J]. Int J Pediatr Otorhinolaryngol, 2018, 112: 109-112. doi:10.1016/j.ijporl.2018.06.017.
[9] 李克鹏, 刘柱, 金书丞, 等. 鼻部横纹肌肉瘤诊疗分析[J]. 临床耳鼻咽喉头颈外科杂志, 2017,31(18): 1398-1401,1407. doi:10.13201/j.issn.1001-1781.2017.18.005. LI Kepeng, LIU Zhu, JIN Shucheng, et al. Clinical analysis of nose rhabdomyosarcoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2017,31(18): 1398-1401,1407. doi:10.13201/j.issn.1001-1781.2017.18.005.
[10] Hicks J, Flaitz C. Rhabdomyosarcoma of the head and neck in children[J]. Oral Oncol, 2002, 38(5): 450-459. doi:10.1016/s1368-8375(01)00105-1.
[11] 彭晓敏, 黎阳, 熊稀霖, 等. 放疗及二次根治手术对儿童横纹肌肉瘤的疗效影响分析[J]. 中国小儿血液与肿瘤杂志, 2021,26(1): 29-34. doi: 10.3969/j.issn.1673-5323.2021.01.005. PENG Xiaomin, LI Yang, XIONG Xilin, et al. Effect of radiotherapy and second radicalsurgery on rhabdomyosarcoma in children[J]. J China Pediatr Blood Cancer, 2021,26(1): 29-34. doi: 10.3969/j.issn.1673-5323.2021.01.005.
[12] Dasgupta R, Fuchs J, Rodeberg D. Rhabdomyosarcoma[J]. Semin Pediatr Surg, 2016, 25(5): 276-283. doi:10.1053/j.sempedsurg.2016.09.011.
[13] Wharam MD, Hanfelt JJ, Tefft MC, et al. Radiation therapy for rhabdomyosarcoma: local failure risk for Clinical Group III patients on Intergroup Rhabdomyosarcoma Study II[J]. Int J Radiat Oncol Biol Phys, 1997, 38(4): 797-804. doi:10.1016/s0360-3016(97)00120-x.
[14] Lockney NA, Friedman DN, Wexler LH, et al. Late toxicities of intensity-modulated radiation therapy for head and neck rhabdomyosarcoma[J]. Pediatr Blood Cancer, 2016, 63(9): 1608-1614. doi:10.1002/pbc.26061.
[15] Hu JW, Liu SL, Qiu JH. Embryonal rhabdomyosarcoma of the middle ear[J]. Otolaryngol Head Neck Surg, 2002, 126(6): 690-692. doi:10.1067/mhn.2002.123922.
[16] Linabery AM, Ross JA. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999[J]. Cancer, 2008, 113(9): 2575-2596. doi:10.1002/cncr.23866.
[17] Skapek SX, Ferrari A, Gupta AA, et al. Rhabdomyosarcoma[J]. Nat Rev Dis Primers, 2019, 5(1): 1-19. doi:10.1038/s41572-018-0051-2.
[18] Hibbitts E, Chi YY, Hawkins DS, et al. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: a report from the Children's Oncology Group[J]. Cancer Med, 2019, 8(14): 6437-6448. doi:10.1002/cam4.2504.
[19] 中华医学会病理学分会儿科病理学组, 中国抗癌协会小儿肿瘤专业委员会病理学组, 福棠儿童医学发展研究中心病理专业委员会. 儿童横纹肌肉瘤病理诊断规范化专家共识[J]. 中华病理学杂志, 2021, 50(10): 1110-1115. doi:10.3760/cma.j.cn112151-20210112-00033. Consensus on the diagnosis of pediatric rhabdomyosarcoma[J]. Chinese Journal of Pathology, 2021, 50(10): 1110-1115. doi:10.3760/cma.j.cn112151-20210112-00033.
[20] Malempati S, Hawkins DS. Rhabdomyosarcoma: review of the Children's Oncology Group(COG)Soft-Tissue Sarcoma Committee experience and rationale for current COG studies[J]. Pediatr Blood Cancer, 2012, 59(1): 5-10. doi:10.1002/pbc.24118.
[21] 徐红艳, 黄慧, 杨文萍. 小儿耳鼻部胚胎性横纹肌肉瘤2例并文献复习[J]. 临床与实验病理学杂志, 2013, 29(4): 445-446. doi:10.13315/j.cnki.cjcep.2013.04.017.

相关文章 15

[1]	杨扬,王晓旭,张杰. 儿童中耳胆脂瘤诊治进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 1-6.
[2]	高信忠,林宗通,沈翎,刘平凡,林兴,许杨杨. 咽鼓管球囊扩张联合腺样体切除术治疗儿童分泌性中耳炎疗效分析[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 7-12.
[3]	焦雪梅,杨扬,李春凤,张晓琳. 鼓膜置管对分泌性中耳炎患儿咽鼓管功能的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(1): 60-63.
[4]	万怡宁,张德军,傅则名,郭芳,郭颖媛,管国芳. 磁共振弥散加权成像在先天性中耳胆脂瘤精准诊断与JOS分期中的应用探讨12例[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 65-69.
[5]	周宇翔综述,苗北平,卢永田审校. 首诊鼻咽癌内镜手术的治疗进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(6): 108-112.
[6]	樊慧娟综述张海利审校. HIF-1α与VEGF在中耳胆脂瘤中的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(5): 93-97.
[7]	吴华,孙永明,郑建华,蔡雪花. 腺样体消融联合鼓膜打孔术治疗儿童腺样体肥大合并分泌性中耳炎55例[J]. 山东大学耳鼻喉眼学报, 2021, 35(2): 71-75.
[8]	李文静综述刘鸣审校. C₂H₂型锌指蛋白家族与喉恶性肿瘤的研究进展[J]. 山东大学耳鼻喉眼学报, 2021, 35(1): 125-130.
[9]	郑朝攀,曾小燕,张博,韩灵,罗曼,马玲国. 内镜经翼突入路切除中颅底恶性肿瘤30例临床分析[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 42-48.
[10]	王海霞,张彩霞,李银银,郑金秀,陈曦. 经鼓室注射内耳钆造影显影不良原因初探[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 61-66.
[11]	魏馨雨,杨方园综述杨军,张青审校. 耳源性细菌性迷路炎研究进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 102-107.
[12]	林宗通,沈翎,杨中婕. 腺样体大小及圆枕类型对儿童分泌性中耳炎的影响[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 121-126.
[13]	谷少尉,侯元友,魏东敏,李文明,陈东彦,徐晨阳,雷大鹏,潘新良. 声门上喉癌舌瓣修补术后吞咽功能恢复[J]. 山东大学耳鼻喉眼学报, 2020, 34(5): 127-131.
[14]	青晓艳, 徐义全综述李超审校. 甲状腺未分化癌的分子机制研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(3): 26-31.
[15]	田雨鑫,王菁菁,王慧,吴雅琴,时海波,陈正侬. 医源性面瘫的手术治疗[J]. 山东大学耳鼻喉眼学报, 2020, 34(1): 20-24.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed